Q1 Results impact: Alkem Labs, PN Gadgil shares rally up to 10% on strong earnings, Granules up 4%

The shares of the company rallied 10 percent to hit the upper circuit at Rs 603.50 apiece. The stock had made a stellar debut in September last year, listing with 73 percent premium to IPO price at Rs 830 apiece. The shares have so far declined more than 27 percent since then.

Alkem Labs Q1 Results:

Alkem Labs reported a net profit of Rs 664 crore for Q1 FY26. This marks a 22 percent on-year rise from the Rs 545 crore net profit reported in Q1 FY25. The firm’s revenue from operations meanwhile rose to Rs 3,371 crore.

Alkem Labs shares rallied 7.5 percent to trade at Rs 5,207 apiece after the results were released. The stock has gained nearly 10 percent in the past six months, but is down over 7 percent in 2025 so far. The shares of the pharma company have gained nearly 77 percent in the past five years.

Granules India Q1 Results:

Granules India reported a net profit of Rs 112.64 crore for Q1 FY26. This marks a 16 percent on-year decline from the Rs 134.65 crore net profit reported in Q1 FY25. The firm’s revenue from operations rose nearly 3 percent on-year to Rs 1,210 crore during the quarter under review.

Granules India shares surged more than 4 percent to trade at Rs 461 apiece. The stock dropped nearly 6 percent in the past one month, and around 15 percent in the past six months. The stock has declined over 23 percent in 2025 so far, but gained over 49 percent in the past five years.

Also read: Our LIVE blog on Q1 results

Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.